Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-06

Clinical Trial Results: Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH) [NA]

View source ↗

Summary

Clinical trial evaluating guanfacine for reversing opioid-induced hyperalgesia in chronic pain patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Chronic Pain | NA | Status: TERMINATED | Results posted: 2026-07-06